Skip to content

Clinical trials

Observational Virus Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Virus Diseases Phase: Observational Clear all

170 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20024
20033
20041
20051
20071
20082
20095
20104
20114
20125
20133
20142
20151
20162
20173
20183
20194
202046
202112
202219
202310
202410
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92
Unknown status39
Recruiting18
Active, not recruiting7
Terminated6
Not yet recruiting5
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ModernaTX, Inc.10
National Institute of Allergy and Infectious Diseases (NIAID)8
Assistance Publique - Hôpitaux de Paris7
National Cancer Institute (NCI)6
Hospices Civils de Lyon4
Chinese University of Hong Kong3
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
National Heart, Lung, and Blood Institute (NHLBI)3
Rigshospitalet, Denmark3
University Hospital, Lille3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Virus Diseases170
COVID-1941
Bacterial Infections25
Coronavirus Infections25
Infections24
Respiratory Tract Infections18
Influenza, Human11
Fever7
DNA Virus Infections6
Pneumonia6

Trials

Showing 76 to 100 of 170. Each trial links to its page on Pharma Observatory.

70 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.